Savage CO, Harper L, Adu D: Primary systemic vasculitis. Lancet. 1997, 349: 553-558. 10.1016/S0140-6736(97)80118-3.
Article
CAS
PubMed
Google Scholar
Seo P, Stone JH: The antineutrophil cytoplasmic antibody-associated vasculitides. Am J Med. 2004, 117: 39-50. 10.1016/j.amjmed.2004.02.030.
Article
CAS
PubMed
Google Scholar
Jennette J, Falk R: Renal and systemic vasculitis. Comprehensive clinical nephrology. Mosby. Edited by: Johnson R, Feehally J. 2003, 341-357. 2
Google Scholar
Jennette JC, Falk RJ: New insight into the pathogenesis of vasculitis associated with antineutrophil cytoplasmic autoantibodies. Curr Opin Rheumatol. 2008, 20: 55-60. 10.1097/BOR.0b013e3282f16c0a.
Article
CAS
PubMed
Google Scholar
Bolton WK, Sturgill BC: Methylprednisolone therapy for acute crescentic rapidly progressive glomerulonephritis. Am J Nephrol. 1989, 9: 368-375. 10.1159/000167998.
Article
CAS
PubMed
Google Scholar
Lockwood CM, Rees AJ, Pearson TA, Evans DJ, Peters DK, Wilson CB: Immunosuppression and plasma-exchange in the treatment of Goodpasture's syndrome. Lancet. 1976, 1: 711-715. 10.1016/S0140-6736(76)93089-0.
Article
CAS
PubMed
Google Scholar
Pusey CD, Rees AJ, Evans DJ, Peters DK, Lockwood CM: Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int. 1991, 40: 757-763. 10.1038/ki.1991.272.
Article
CAS
PubMed
Google Scholar
Rondeau E, Levy M, Dosquet P, Ruedin P, Mougenot B, Kanfer A, Sraer JD: Plasma exchange and immunosuppression for rapidly progressive glomerulonephritis: prognosis and complications. Nephrol Dial Transplant. 1989, 4: 196-200.
CAS
PubMed
Google Scholar
Lapraik C, Watts R, Bacon P, Carruthers D, Chakravarty K, D'Cruz D, Guillevin L, Harper L, Jayne D, Luqmani R, Mooney J, Scott D: BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis. Rheumatology (Oxford). 2007, 46: 1615-1616. 10.1093/rheumatology/kem146a.
Article
CAS
Google Scholar
Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, Hauser T, Hellmich B, Jayne D, Kallenberg CGM, Merkel PA, Raspe H, Salvarani C, Scott DGI, Stegeman C, Watts R, Westman K, Witter J, Yazici H, Luqmani R: EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis. 2009, 68: 310-317. 10.1136/ard.2008.088096.
Article
CAS
PubMed
Google Scholar
Menahem S, Hiremagalur B, Mudge D, Toussaint N, Walters G: The CARI guidelines. 25 Induction and maintenance therapy in ANCA-associated systemic vasculitis. Nephrology (Carlton). 2008, 13 (Suppl 2): S24-36. 10.1111/j.1440-1797.2008.00995.x.
Article
Google Scholar
Jayne D: Challenges in the management of microscopic polyangiitis: past, present and future. Curr Opin Rheumatol. 2008, 20: 3-9. 10.1097/BOR.0b013e3282f370d1.
Article
PubMed
Google Scholar
de Groot K, Adu D, Savage CO: The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review. Nephrol Dial Transplant. 2001, 16: 2018-2027. 10.1093/ndt/16.10.2018.
Article
CAS
PubMed
Google Scholar
Kerr PG, Chadban SJ, Atkins RC: Is there a role for plasma exchange in rapidly progressive glomerulonephritis?. Nephrology. 2001, 6: 141-143. 10.1046/j.1440-1797.2001.00052.x.
Article
Google Scholar
Levy JB, Winearls CG: Rapidly progressive glomerulonephritis: what should be first-line therapy?. Nephron. 1994, 67: 402-407. 10.1159/000188012.
Article
CAS
PubMed
Google Scholar
Jayne DR, Chapel H, Adu D, Misbah S, O'Donoghue D, Scott D, Lockwood CM: Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. QJM. 2000, 93: 433-439. 10.1093/qjmed/93.7.433.
Article
CAS
PubMed
Google Scholar
Nowack R, Birck R, van der Woude FJ: Mycophenolate mofetil for systemic vasculitis and IgA nephropathy. Lancet. 1997, 349: 774-10.1016/S0140-6736(05)60198-5.
Article
CAS
PubMed
Google Scholar
Tervaert JW, Stegeman CA, Kallenberg CG: Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis. Curr Opin Nephrol Hypertens. 2001, 10: 211-217. 10.1097/00041552-200103000-00009.
Article
CAS
PubMed
Google Scholar
Walters G, Willis NS, Craig JC: Interventions for renal vasculitis in adults. Cochrane Database Syst Rev. 2008, CD003232-
Google Scholar
de Groot K, Harper L, Jayne DRW, Flores Suarez LF, Gregorini G, Gross WL, Luqmani R, Pusey CD, Rasmussen N, Sinico RA, Tesar V, Vanhille P, Westman K, Savage COS: Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. Ann Intern Med. 2009, 150: 670-680.
Article
PubMed
Google Scholar
Hu W, Liu C, Xie H, Chen H, Liu Z, Li L: Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal 26 involvement. Nephrol Dial Transplant. 2008, 23: 1307-1312. 10.1093/ndt/gfm780.
Article
CAS
PubMed
Google Scholar
Metzler C, Miehle N, Manger K, Iking-Konert C, de Groot K, Hellmich B, Gross WL, Reinhold-Keller E: Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis. Rheumatology (Oxford). 2007, 46: 1087-1091. 10.1093/rheumatology/kem029.
Article
CAS
Google Scholar
Pagnoux C, Mahr A, Hamidou MA, Boffa J, Ruivard M, Ducroix J, Kyndt X, Lifermann F, Papo T, Lambert M, Le Noach J, Khellaf M, Merrien D, Puéchal X, Vinzio S, Cohen P, Mouthon L, Cordier J, Guillevin L: Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. N Engl J Med. 2008, 359: 2790-2803. 10.1056/NEJMoa0802311.
Article
CAS
PubMed
Google Scholar
Stone J, Merkel P, Seo P, Spiera R, Langford C, Hoffman G, Kallenberg C, William St Clair E, Fessler B, Tchao N, Ding L, Webber L, Ikle D, Weitzenkamp D, Wu W, Brunetta P, Seismundo L, Fervenza F, Keogh K, Kissin E, Mieras K, Monach P, Peikert T, Stegeman C, Ytterberg S, Specks U: Rituximab versus cyclophosphamide for induction of remission of anca associated vasculitis: a randomized controlled trial (rave) [abstract]. American College of Rheumatology Annual Meeting. Philadelphia. 2009
Google Scholar
Jones R, Walsh M, Jayne D, for the European Vasculitis Study Group: Randomised trial of rituximab versus cyclophophamide for anca associated renal vasculitis: rituxvas [abstract]. Annual Scientific Meeting of the American Society of Nephrology. 2008
Google Scholar
The Wegener's Granulomatosis Etanercept Trial (WGET) Research Group: Etanercept plus standard therapy for Wegener's granulomatosis. N Engl J Med. 2005, 352: 351-361. 10.1056/NEJMoa041884.
Article
Google Scholar
Dickersin K, Scherer R, Lefebvre C: Identifying relevant studies for systematic reviews. BMJ. 1994, 309: 1286-1291.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lefebvre C, McDonald S: Development of a Sensitive Search Strategy for Reports of Randomized Controlled Trials in EMBASE. Fourth International Cochrane Colloquium; Adelaide. 1996
Google Scholar
Cole E, Cattran D, Magil A, Greenwood C, Churchill D, Sutton D, Clark W, Morrin P, Posen G, Bernstein K: A prospective randomized trial of plasma exchange as additive therapy in idiopathic crescentic glomerulonephritis. The Canadian Apheresis Study Group. Am J Kidney Dis. 1992, 20: 261-269.
Article
CAS
PubMed
Google Scholar
Glöckner WM, Sieberth HG, Wichmann HE, Backes E, Bambauer R, Boesken WH, Bohle A, Daul A, Graben N, Keller F: Plasma exchange and immunosuppression in rapidly progressive glomerulonephritis: a controlled, multi-center study. Clin Nephrol. 1988, 29: 1-8.
PubMed
Google Scholar
Jayne DRW, Gaskin G, Rasmussen N, Abramowicz D, Ferrario F, Guillevin L, Mirapeix E, Savage COS, Sinico RA, Stegeman CA, Westman KW, van der Woude FJ, de Lind van Wijngaarden RAF, Pusey CD: Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol. 2007, 18: 2180-2188. 10.1681/ASN.2007010090.
Article
CAS
PubMed
Google Scholar
Mauri J, Gonzalez M, Poveda R: Therapeutic plasma exchange in the treatment of rapidly progressive glomerulonphritis. Plasma therapy and transfusion technology. 1985, 6: 587-591.
Google Scholar
Rifle G, Chalopin JM, Zech P, Deteix P, Ducret F, Vialtel P, Cordonnier D: Treatment of idiopathic acute crescentic glomerulonephritis by immunodepression and plasma-exchanges. A prospective randomised study. Proc Eur Dial Transplant Assoc. 1981, 18: 493-502.
CAS
PubMed
Google Scholar
Adu D, Pall A, Luqmani RA, Richards NT, Howie AJ, Emery P, Michael J, Savage CO, Bacon PA: Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis. QJM. 1997, 90: 401-409. 10.1093/qjmed/90.6.401.
Article
CAS
PubMed
Google Scholar
Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, Lesavre P, Jacquot C, Bindi P, Bielefeld P, Desson JF, Détrée F, Dubois A, Hachulla E, Hoen B, Jacomy D, Seigneuric C, Lauque D, Stern M, Longy-Boursier M: A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis. Arthritis Rheum. 1997, 40: 2187-2198. 10.1002/art.1780401213.
Article
CAS
PubMed
Google Scholar
Haubitz M, Schellong S, Göbel U, Schurek HJ, Schaumann D, Koch KM, Brunkhorst R: Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: a prospective, randomized study. Arthritis Rheum. 1998, 41: 1835-1844. 10.1002/1529-0131(199810)41:10<1835::AID-ART16>3.0.CO;2-Q.
Article
CAS
PubMed
Google Scholar
Furuta T, Hotta O, Yusa N, Horigome I, Chiba S, Taguma Y: Lymphocytapheresis to treat rapidly progressive glomerulonephritis: a randomised comparison with steroid-pulse treatment. Lancet. 1998, 352: 203-204. 10.1016/S0140-6736(05)77809-0.
Article
CAS
PubMed
Google Scholar
Stegmayr BG, Almroth G, Berlin G, Fehrman I, Kurkus J, Norda R, Olander R, Sterner G, Thysell H, Wikström B, Wirén JE: Plasma exchange or immunoadsorption in patients with rapidly progressive crescentic glomerulonephritis. A Swedish multi-center study. Int J Artif Organs. 1999, 22: 81-87.
CAS
PubMed
Google Scholar
Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JWC, Dadoniené J, Ekstrand A, Gaskin G, Gregorini G, de Groot K, Gross W, Hagen EC, Mirapeix E, Pettersson E, Siegert C, Sinico A, Tesar V, Westman K, Pusey C: A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med. 2003, 349: 36-44. 10.1056/NEJMoa020286.
Article
CAS
PubMed
Google Scholar
Hiemstra T, Walsh M, Schmitt W, Jayne D: Randomised controlled trial of mycophenolate mofetil versus azathioprine for maintenance therapy in anca associated vasculitis (improve) [abstract]. Annual Scientific Meeting of the American Society of Nephrology. 2009
Google Scholar
Stegeman CA, Tervaert JW, de Jong PE, Kallenberg CG: Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. N Engl J Med. 1996, 335: 16-20. 10.1056/NEJM199607043350103.
Article
CAS
PubMed
Google Scholar
Rüth E, Kemper MJ, Leumann EP, Laube GF, Neuhaus TJ: Children with steroid-sensitive nephrotic syndrome come of age: long-term outcome. J Pediatr. 2005, 147: 202-207. 10.1016/j.jpeds.2005.03.050.
Article
PubMed
Google Scholar
Bosch X, Guilabert A, Espinosa G, Mirapeix E: Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a systematic review. JAMA. 2007, 298: 655-669. 10.1001/jama.298.6.655.
Article
CAS
PubMed
Google Scholar